Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31896 total
The September US jobs report came in below expectations on 2 October. Futures for the SPY and QQQ moved higher on the miss. Markets are pricing in a faster path to rate cuts. Options bets this week tell a two-sided…
Earnings season kicks off in earnest this week. Over 200 companies are scheduled to report globally, with the biggest US names arriving late in the week. Today sees Jefferies Financial Group post fiscal Q3 results…
Consensus price targets on NKE fell to $42.41 from $45.63, the largest cut among major names in today's analyst activity. The move extends a difficult stretch for the sportswear giant. Short interest stands at 8.4% of…
The most striking cluster of recent filings comes from ESSITY B, the Swedish hygiene group. Industrivarden, an investment company with board representation, bought roughly $24M of shares across multiple tranches on…
Short sellers made aggressive moves across several mid-cap names in the week to October 1. A global bond selloff added pressure to equity markets, with US 10-year Treasury yields at their highest since 2002. The…
Short sellers have quietly exited NU over the past two weeks. Retail traders have piled in at precisely the wrong moment. The gap between those two movements is the story. Short interest in Nu Holdings fell 19.8% over…
Ford has shed 12% in a month and now trades at $12.27, more than 23% below the average analyst price target of $16.03. Short positions have continued to build. The Q3 earnings date is 24 days away. Short interest…
A convergence report published earlier today covered the Piper Sandler downgrade and the initial short interest build on EQBK. Since then, the cost to borrow has broken sharply higher. That move deserves its own…
Options traders have built the most heavily put-skewed position in Piper Sandler's 52-week history. Short sellers are adding exposure at the same time. The stock is down 7.5% over the past week. The put-call ratio on…
The retreat by short sellers in Solstice Advanced Materials has continued since Tuesday's note, and options positioning has grown even more one-sided. Two days on, both signals are more pronounced. Short interest now…
William Blair's downgrade arrived just before AYI reported. The stock fell 3.4% over the past week. Now short interest is climbing back, and the cost to borrow has followed. Why this matters: Three signals are moving…
Why this matters: Three distinct data streams are moving simultaneously on ABBV. Retail attention has jumped to nearly three standard deviations above its 90-day norm. Short sellers have been cutting positions for…
Why this matters: JPMorgan Chase has spent two weeks shedding short positions. Now, 11 days before Q3 earnings, the cost to borrow its shares has spiked 144% in a week. Short interest is at a six-month low. The borrow…
Three distinct signals converged on EQBK this week. Piper Sandler downgraded the stock. Short interest jumped sharply. Put buying hit its highest level since August. With earnings eleven days away and the Lincoln…
Rothschild & Co upgraded Abbott Laboratories to Buy this morning, lifting its target to $127 from $119. The stock trades at $96.69, implying 31% upside to the new target. The timing matters: earnings are due October…
South Korean markets fell more than 5% overnight, pulling AI-linked chip stocks lower across the board. NVIDIA and ON Semiconductor are both in focus as traders pile into semiconductor hedges. Options volume in chip…
CareTrust REIT saw its options put/call ratio hit 3.70 on Friday, the highest reading in 52 weeks. The stock fell 1.8% on the day. That ratio means traders bought 3.7 put contracts for every call, a signal of sharp…
Jefferies Financial Group kicks off the week today, reporting Q3 2026 results after the close. The investment bank carries a $10.4 billion market cap into the print. IDT Corporation also reports today, after the…
September 2026 delivered a stark contrast in vehicle data. New passenger-car registrations in the Netherlands fell to 27,882, according to the Dutch vehicle registration series, which dates to 2011. That is the…
REGN received the headline call of the day. An analyst upgraded the $74 billion pharma group, lifting the consensus average target price to $853. Short interest sits at just 2.6% of free float, a low reading for a name…
